beta-alanine has been researched along with Cerebral Hemorrhage in 28 studies
Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A network meta-analysis of the three new oral anticoagulants was performed from the three trials comparing dabigatran, rivaroxaban and apixaban with warfarin in patients with atrial fibrillation." | 8.88 | Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. ( Diener, HC; Harenberg, J; Lip, GY; Marder, VJ; Marx, S; Wehling, M; Weiss, C, 2012) |
| "This experimental study of a rat ICH model indicates that dabigatran-related ICH may not increase the risk of delayed hematoma expansion." | 7.81 | Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage? ( Hirose, Y; Inamasu, J; Tanoue, S; Toyama, H; Yamada, M, 2015) |
| "Warfarin-related intracerebral hemorrhage carries a particularly high risk of neurologic deterioration and death because of a high rate of hematoma expansion of about 50%." | 5.40 | Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion. ( Damgaard, D; Simonsen, CZ; Steiner, T; Tietze, A, 2014) |
| "Ischemic stroke was induced by transient middle cerebral artery occlusion (tMCAO) for 1 h or 3 h." | 5.38 | No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke. ( Bohmann, F; Foerch, C; Lindhoff-Last, E; Mirceska, A; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H, 2012) |
| "A network meta-analysis of the three new oral anticoagulants was performed from the three trials comparing dabigatran, rivaroxaban and apixaban with warfarin in patients with atrial fibrillation." | 4.88 | Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. ( Diener, HC; Harenberg, J; Lip, GY; Marder, VJ; Marx, S; Wehling, M; Weiss, C, 2012) |
| "This experimental study of a rat ICH model indicates that dabigatran-related ICH may not increase the risk of delayed hematoma expansion." | 3.81 | Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage? ( Hirose, Y; Inamasu, J; Tanoue, S; Toyama, H; Yamada, M, 2015) |
| "Severe bleeding associated with dabigatran frequently requires intensive care management." | 3.81 | Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran. ( Bernier-Jean, A; Bouchard, J; Eris, JM; Ghannoum, M; Kershaw, G; Patel, JP; Roberts, DM; Tran, H; Weatherburn, C; Williamson, D, 2015) |
| "Lack of specific antidotes is a major concern in intracerebral hemorrhage (ICH) related to direct anticoagulants including dabigatran (OAC-ICH)." | 3.81 | Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran. ( Mracsko, E; Na, SY; van Ryn, J; Veltkamp, R, 2015) |
| "Due to lack of an available antidote, activated prothrombin complex concentrate was utilized as a nonspecific procoagulant to stabilize an intracerebral hemorrhage in a patient on dabigatran." | 3.80 | Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report. ( Faust, AC; Peterson, EJ, 2014) |
| " We determined intracerebral hemorrhage volume and functional outcome in a standardized TBI model in mice treated with warfarin or dabigatran." | 3.80 | Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation. ( Foerch, C; Lauer, A; Leung, W; Lo, EH; Lok, J; Schaefer, JH; Van Cott, EM; van Leyen, K; van Ryn, J; Whalen, M; Wu, L, 2014) |
| "Dabigatran etexilate (DE) has recently been introduced for stroke prevention in atrial fibrillation, but management of acute ischaemic stroke during therapy with DE is a challenge." | 3.79 | Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia. ( Ploen, R; Sun, L; Veltkamp, R; Zhou, W; Zorn, M, 2013) |
| "Dabigatran has the advantage of providing rapid and steady anticoagulation without requiring laboratory monitoring." | 2.49 | Dabigatran: a primer for neurosurgeons. ( Fugate, JE; Lanzino, G; McBane, RD; Rabinstein, AA, 2013) |
| "Stroke is a common disease, which is associated with high morbidity and high mortality." | 2.49 | [Anticoagulant therapy in stroke patients]. ( Grove, EL; Husted, SE; Kraglund, KL; Modrau, B, 2013) |
| "Warfarin-related intracerebral hemorrhage carries a particularly high risk of neurologic deterioration and death because of a high rate of hematoma expansion of about 50%." | 1.40 | Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion. ( Damgaard, D; Simonsen, CZ; Steiner, T; Tietze, A, 2014) |
| "Contrast medium extravasation (CE) in intracerebral hemorrhage (ICH) is a marker of ongoing bleeding and a predictor of hematoma expansion." | 1.39 | Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography. ( Dinkel, J; Foerch, C; Gupta, R; Hayakawa, K; Karatas, H; Lauer, A; Leung, W; Lo, EH; Schlunk, F; Steinmetz, H; Won, SY, 2013) |
| "Ischemic stroke was induced by transient middle cerebral artery occlusion (tMCAO) for 1 h or 3 h." | 1.38 | No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke. ( Bohmann, F; Foerch, C; Lindhoff-Last, E; Mirceska, A; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 28 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, L | 1 |
| Zhou, W | 2 |
| Ploen, R | 1 |
| Zorn, M | 2 |
| Veltkamp, R | 3 |
| Bauer, KA | 1 |
| Won, SY | 1 |
| Schlunk, F | 1 |
| Dinkel, J | 1 |
| Karatas, H | 1 |
| Leung, W | 2 |
| Hayakawa, K | 1 |
| Lauer, A | 2 |
| Steinmetz, H | 3 |
| Lo, EH | 2 |
| Foerch, C | 4 |
| Gupta, R | 1 |
| Simonsen, CZ | 1 |
| Steiner, T | 1 |
| Tietze, A | 1 |
| Damgaard, D | 1 |
| Yasaka, M | 2 |
| Okada, Y | 2 |
| Laroche, JP | 1 |
| Hanon, O | 1 |
| Faust, AC | 1 |
| Peterson, EJ | 1 |
| Schaefer, JH | 1 |
| Wu, L | 1 |
| Van Cott, EM | 1 |
| Lok, J | 1 |
| Whalen, M | 1 |
| van Leyen, K | 1 |
| van Ryn, J | 3 |
| Konturek, P | 1 |
| Hess, T | 1 |
| Hana, A | 2 |
| Berthold, C | 1 |
| Gunness, VR | 1 |
| Dooms, G | 1 |
| Standhardt, H | 1 |
| Koy, J | 1 |
| Matgé, G | 1 |
| Boecher-Schwarz, H | 1 |
| Hertel, F | 1 |
| Ammollo, CT | 1 |
| Zaccaria, F | 1 |
| Visino, F | 1 |
| Testa, S | 1 |
| Semeraro, N | 1 |
| Colucci, M | 1 |
| Tanoue, S | 1 |
| Inamasu, J | 1 |
| Yamada, M | 1 |
| Toyama, H | 1 |
| Hirose, Y | 1 |
| Bouchard, J | 1 |
| Ghannoum, M | 1 |
| Bernier-Jean, A | 1 |
| Williamson, D | 1 |
| Kershaw, G | 1 |
| Weatherburn, C | 1 |
| Eris, JM | 1 |
| Tran, H | 1 |
| Patel, JP | 1 |
| Roberts, DM | 1 |
| Na, SY | 1 |
| Mracsko, E | 1 |
| Michota, F | 1 |
| Schwarting, S | 1 |
| Illanes, S | 1 |
| Liesz, A | 1 |
| Middelhoff, M | 1 |
| Bendszus, M | 1 |
| Heiland, S | 1 |
| Casado Naranjo, I | 1 |
| Portilla-Cuenca, JC | 1 |
| Jiménez Caballero, PE | 1 |
| Calle Escobar, ML | 1 |
| Romero Sevilla, RM | 1 |
| Dempfle, CE | 1 |
| Hennerici, MG | 1 |
| Diener, HC | 2 |
| Eikelboom, J | 1 |
| Granger, CB | 1 |
| Hacke, W | 1 |
| Moll, S | 1 |
| Pfeilschifter, W | 2 |
| Bohmann, F | 2 |
| Baumgarten, P | 1 |
| Mittelbronn, M | 1 |
| Pfeilschifter, J | 2 |
| Lindhoff-Last, E | 2 |
| Kowey, PR | 1 |
| Naccarelli, GV | 1 |
| Fugate, JE | 1 |
| Rabinstein, AA | 1 |
| McBane, RD | 1 |
| Lanzino, G | 1 |
| Harenberg, J | 1 |
| Marx, S | 1 |
| Lip, GY | 1 |
| Marder, VJ | 1 |
| Wehling, M | 1 |
| Weiss, C | 1 |
| Mirceska, A | 1 |
| Kraglund, KL | 1 |
| Husted, SE | 1 |
| Modrau, B | 1 |
| Grove, EL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation[NCT03021928] | Phase 3 | 200 participants (Actual) | Interventional | 2017-06-14 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for beta-alanine and Cerebral Hemorrhage
| Article | Year |
|---|---|
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation | 2013 |
[Novel oral anticoagulants and atrial fibrillation in the elderly].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; | 2013 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacemen | 2014 |
NOAC and intracerebral bleeding--presentation of four cases and review of the literature.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabiga | 2014 |
Intracerebral hemorrhage: Pick your poison.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chronic Disease; Dabigatran; Huma | 2010 |
Dabigatran: a primer for neurosurgeons.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Hum | 2013 |
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cereb | 2012 |
[Anticoagulant therapy in stroke patients].
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral He | 2013 |
20 other studies available for beta-alanine and Cerebral Hemorrhage
| Article | Year |
|---|---|
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood-Brain Barrier; Cerebral | 2013 |
Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cer | 2013 |
Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cereb | 2014 |
[Prevention and treatment of major bleeding during anticoagulation].
Topics: Administration, Oral; Alcohol Drinking; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemor | 2013 |
[New anticoagulants: stop or more?].
Topics: Adverse Drug Reaction Reporting Systems; Anticoagulants; Antidotes; Benzimidazoles; beta-Alanine; Ce | 2014 |
Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral | 2014 |
Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Factors; | 2014 |
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding.
Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Case-Control St | 2015 |
Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage?
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Collagenases; Dabigatran; | 2015 |
Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagu | 2015 |
Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
Topics: Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alan | 2015 |
Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Brain; Cerebral Hemorrhage; | 2011 |
Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Cerebrovascular Circulation; | 2011 |
Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
Topics: Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Fibrinolytic Agents; Humans; Male; St | 2011 |
The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrha | 2012 |
Letter by Moll regarding article, "Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran".
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Brain; Cerebral Hemorrhage | 2012 |
Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Disease Mode | 2012 |
The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; | 2012 |
No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.
Topics: Administration, Oral; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cereb | 2012 |
[Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Humans | 2012 |